Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Atillasoy Ercem
See Remarks at Kalaris Therapeutics. Filing since 3 Aug 2020.
CIK 0001818802
Company
Date
Role
Action
Shares
Amount
Of holding
KLRS
Kalaris Therapeutics, Inc.
20 Oct 2022
See Remarks
Sold, plan not stated
1,527
$12.96K
1.1%
KLRS
Kalaris Therapeutics, Inc.
19 Oct 2022
See Remarks
Sold, plan not stated
568
$5.32K
0.4%
KLRS
Kalaris Therapeutics, Inc.
21 Jul 2022
See Remarks
Sold, plan not stated
1,533
$8.25K
1.1%
KLRS
Kalaris Therapeutics, Inc.
20 Jul 2022
See Remarks
Sold, plan not stated
563
$2.94K
0.4%
KLRS
Kalaris Therapeutics, Inc.
21 Apr 2022
See Remarks
Sold, plan not stated
1,587
$9.30K
1.3%
KLRS
Kalaris Therapeutics, Inc.
20 Apr 2022
See Remarks
Sold, plan not stated
453
$3.03K
0.4%
KLRS
Kalaris Therapeutics, Inc.
25 Jan 2022
See Remarks
Sold, plan not stated
4,639
$38.25K
4.4%
KLRS
Kalaris Therapeutics, Inc.
21 Oct 2021
See Remarks
Sold, plan not stated
1,514
$36.69K
1.4%
KLRS
Kalaris Therapeutics, Inc.
3 Aug 2020
See Remarks
Bought
3,500
$59.50K
4.7%
9 decisions on file.
